» Articles » PMID: 28441707

Fentanyl Inhibits Tumorigenesis from Human Breast Stem Cells by Inducing Apoptosis

Overview
Specialty Oncology
Date 2017 Apr 27
PMID 28441707
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Fentanyl is an opioid analgesic that it is widely used in cancer patients. Since there have been reports of effects of analgesic medications on the recurrence and development of resistance to treatment, influences of of fentanyl on MCF-7 and HEK293 cells were evaluated. Cell viability and apoptosis were assessed by MTT assay and flow cytometry, respectively. Gene expression analysis was performed by quantitative real-time PCR assay for the Oct4, Sox2 and Nanog genes as stem cell markers and Bax, Bcl2, and p53 genes as apoptosis markers. MTT assay results showed that fentanyl significantly inhibited the growth of MCF-7 cells in a dose-and time-dependent manner while significantly increasing apoptosis. In contrast, decrease was noted in HEK-293 cells. In MCF-7 derived cancer stem cells, fentanyl treatment decreased the expression of Bax, Bcl2, Oct4, Sox2, Nanog genes when compared to untreated cells. In HEK-293 stem cells, decrease was noted for Sox2, Nanog and Bax, but increase for Oct4. Our study supports an antitumor role of fentanyl by inducing apoptosis and reducing numbers of cancer stem cells in the MCF-7 human breast adenocarcinoma line.

Citing Articles

Evaluation of the Effects of Opium on the Expression of and in Wistar Rat Bladder.

Oskouie I, Zareian Baghdadabad L, Mashhadi R, Zahmatkesh P, Mirzaei A, Khajavi A Bladder Cancer. 2024; 10(1):47-59.

PMID: 38993529 PMC: 11181810. DOI: 10.3233/BLC-230076.


Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway.

Zhang X, Han Z, Li Z, Wang T Open Med (Wars). 2023; 18(1):20230730.

PMID: 37305523 PMC: 10251164. DOI: 10.1515/med-2023-0730.


Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review.

Constance J, McFarland M, Casucci T, Deininger M, Enioutina E, Job K JMIR Res Protoc. 2023; 12:e38167.

PMID: 37213193 PMC: 10242459. DOI: 10.2196/38167.


Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid receptor-dependent activation of EGFR.

Xiao K, Zheng Q, Bao L BMC Anesthesiol. 2022; 22(1):268.

PMID: 35999506 PMC: 9396929. DOI: 10.1186/s12871-022-01812-4.


The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro.

Kong L, Shata M, Brown J, Lyons M, Sherman K, Blackard J J Neurovirol. 2022; 28(4-6):583-594.

PMID: 35976538 PMC: 11135282. DOI: 10.1007/s13365-022-01090-3.


References
1.
Kaur S, Singh G, Kaur K . Cancer stem cells: an insight and future perspective. J Cancer Res Ther. 2015; 10(4):846-52. DOI: 10.4103/0973-1482.139264. View

2.
Greco M, Corli O, Montanari M, Deandrea S, Zagonel V, Apolone G . Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the Cancer Pain Outcome Research Study Group. Clin J Pain. 2010; 27(1):9-18. DOI: 10.1097/AJP.0b013e3181edc250. View

3.
Rauck R, Tark M, Reyes E, Hayes T, Bartkowiak A, Hassman D . Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain. Curr Med Res Opin. 2009; 25(12):2877-85. DOI: 10.1185/03007990903368310. View

4.
Chabner B, Roberts Jr T . Timeline: Chemotherapy and the war on cancer. Nat Rev Cancer. 2005; 5(1):65-72. DOI: 10.1038/nrc1529. View

5.
Greaves M, Maley C . Clonal evolution in cancer. Nature. 2012; 481(7381):306-13. PMC: 3367003. DOI: 10.1038/nature10762. View